AIM: To investigate the expression pattern of clusterin in colorectal adenoma-carcinoma-metastasis series, and to explore the potential role of clusterin in multistage colorectal tumorigenesis and progression. METHODS: A colorectal carcinoma (CRC)-tissue microarray (TMA), which contained 85 advanced CRCs including 43 cases of Dukes B, 21 of Dukes C and 21 of Dukes D tumors, were used for assessing the expression of clusterin (clone 41D) and tumor cell apoptotic index (AI) by immunohistochemistry and TUNEL assay, respectively. Moreover the potential correlation of clusterin expression with the patient's clinical-pathological features were also examined. RESULTS: The positive staining of clusterin in different colorectal tissues was primarily a cytoplasmic pattern. Cytoplasmic overexpression of clusterin was detected in none of the normal colorectal mucosa, 17% of the adenomas, 46% of the primary CRCs, and 57% of the CRC metastatic lesions. In addition, a significant positive correlation between overexpression of clusterin and advanced clinical (Dukes) stage was observed (P<0.01). Overexpression of cytoplasmic clusterin in CRCs was inversely correlated with tumor apoptotic index (P<0.01), indicating the anti-apoptotic function of cytoplasmic clusterin in CRCs. CONCLUSION: These data suggests that overexpression of cytoplasmic clusterin might be involved in the tumorigenesis and/or progression of CRCs. The anti-apoptotic function of cytoplasmic clusterin may be responsible, at least in part, for the development and biologically aggressive behavior of CRC.
AIM: To investigate the expression pattern of clusterin in colorectal adenoma-carcinoma-metastasis series, and to explore the potential role of clusterin in multistage colorectal tumorigenesis and progression. METHODS: A colorectal carcinoma (CRC)-tissue microarray (TMA), which contained 85 advanced CRCs including 43 cases of Dukes B, 21 of Dukes C and 21 of Dukes D tumors, were used for assessing the expression of clusterin (clone 41D) and tumor cell apoptotic index (AI) by immunohistochemistry and TUNEL assay, respectively. Moreover the potential correlation of clusterin expression with the patient's clinical-pathological features were also examined. RESULTS: The positive staining of clusterin in different colorectal tissues was primarily a cytoplasmic pattern. Cytoplasmic overexpression of clusterin was detected in none of the normal colorectal mucosa, 17% of the adenomas, 46% of the primary CRCs, and 57% of the CRC metastatic lesions. In addition, a significant positive correlation between overexpression of clusterin and advanced clinical (Dukes) stage was observed (P<0.01). Overexpression of cytoplasmic clusterin in CRCs was inversely correlated with tumor apoptotic index (P<0.01), indicating the anti-apoptotic function of cytoplasmic clusterin in CRCs. CONCLUSION: These data suggests that overexpression of cytoplasmic clusterin might be involved in the tumorigenesis and/or progression of CRCs. The anti-apoptotic function of cytoplasmic clusterin may be responsible, at least in part, for the development and biologically aggressive behavior of CRC.
Authors: Konstantin S Leskov; Dmitry Y Klokov; Jing Li; Timothy J Kinsella; David A Boothman Journal: J Biol Chem Date: 2003-01-24 Impact factor: 5.157
Authors: P Wong; B A Pfeffer; S L Bernstein; M L Chambers; G J Chader; Z F Zakeri; Y Q Wu; M R Wilson; S P Becerra Journal: Mol Vis Date: 2000-10-27 Impact factor: 2.367
Authors: Dan Xie; Jonathan S T Sham; Wei-Fen Zeng; Han-Liang Lin; Li-Hong Che; Hui-Xi Wu; Jian-Ming Wen; Yan Fang; Liang Hu; Xin-Yuan Guan Journal: Int J Cancer Date: 2003-12-20 Impact factor: 7.396
Authors: J Lakins; S A Bennett; J H Chen; J M Arnold; C Morrissey; P Wong; J O'Sullivan; M Tenniswood Journal: J Biol Chem Date: 1998-10-23 Impact factor: 5.157
Authors: J Steinberg; R Oyasu; S Lang; S Sintich; A Rademaker; C Lee; J M Kozlowski; J A Sensibar Journal: Clin Cancer Res Date: 1997-10 Impact factor: 12.531
Authors: Cun Wang; Kai Jiang; Dongmei Gao; Xiaonan Kang; Chun Sun; Qinle Zhang; Yan Li; Lu Sun; Shu Zhang; Kun Guo; Yinkun Liu Journal: PLoS One Date: 2013-02-14 Impact factor: 3.240
Authors: Juan Ramón Padilla-Mendoza; Arturo Contis-Montes de Oca; Mario Alberto Rodríguez; Mavil López-Casamichana; Jeni Bolaños; Laura Itzel Quintas-Granados; Octavio Daniel Reyes-Hernández; Fabiola Fragozo-Sandoval; Aldo Arturo Reséndiz-Albor; Claudia Vanessa Arellano-Gutiérrez; Israel López-Reyes Journal: Biomed Res Int Date: 2020-04-02 Impact factor: 3.411